Skip to content

ELV

Elevance Health, Inc.

Stock

$386.43+4.76 (+1.25%)Close Oct 2, 2026

Income statement

LineLast 12 months202520242023202220212020201920182017201620152014201320122011201020092008
Revenue$201.1B$199.1B$177.0B$171.3B$156.6B$138.6B$121.9B$104.2B$92.1B$90.0B$84.9B$79.2B$73.9B$71.0B$61.5B$60.7B$58.7B$64.9B$61.3B
SG&A$22.6B$21.0B$20.0B$20.1B$17.7B$15.9B$17.5B$13.4B$14.0B$12.7B$12.6B$12.5B$11.7B$10.0B$8.7B$8.4B$8.7B$9.0B$8.5B
Operating income$5.5B$7.2B$7.9B$8.5B$8.3B$7.6B$6.4B$6.0B$5.4B$4.2B$4.8B$4.8B$4.4B$4.0B$3.6B$3.8B$4.1B$4.2B$4.3B
Non-operating income$409M−$489M$42M−$784M−$683M$436M−$122M−$14M−$358M−$211M−$246M−$122M−$50M−$161M$238M$176M$276M$3.2B−$1.2B
Pretax income$5.9B$6.7B$7.9B$7.7B$7.6B$8.0B$6.2B$6.0B$5.1B$4.0B$4.6B$4.6B$4.4B$3.8B$3.9B$4.0B$4.4B$7.4B$3.1B
Taxes$899M$1.0B$1.9B$1.7B$1.7B$1.8B$1.7B$1.2B$1.3B$121M$2.1B$2.1B$1.8B$1.4B$1.2B$1.3B$1.5B$2.7B$632M
Net income$5.0B$5.7B$6.0B$6.0B$5.9B$6.2B$4.6B$4.8B$3.8B$3.8B$2.5B$2.6B$2.6B$2.5B$2.7B$2.6B$2.9B$4.7B$2.5B
Diluted EPS$22.50$25.21$25.68$25.22$24.28$24.95$17.98$18.47$14.19$14.35$9.21$9.38$8.99$8.20$8.18$7.25$6.94$9.88$4.76
Diluted shares—224.6M232.9M237.4M242.8M246.8M254.3M260.3M264.2M267.8M268.1M272.9M285.9M303.8M324.8M365.1M415.8M480.5M523.0M
Revenue growth—+12.5%+3.3%+9.4%+13.0%+13.8%+16.9%+13.1%+2.3%+6.1%+7.2%+7.2%+4.0%+15.5%+1.3%+3.4%−9.6%+6.0%—
Operating margin2.7%3.6%4.4%5.0%5.3%5.5%5.2%5.8%5.9%4.6%5.7%6.0%6.0%5.6%5.9%6.2%6.9%6.4%7.1%
Net margin2.5%2.8%3.4%3.5%3.8%4.4%3.8%4.6%4.1%4.3%2.9%3.2%3.5%3.5%4.3%4.4%4.9%7.3%4.1%

Revenue to net income